Navigation Links
Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
Date:11/3/2011

record successfully developing and commercializing diagnostic products; (3) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its future diagnostic products; (4) uncertainty of the size of market for its existing diagnostic tests or future diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; (5) uncertainty that Vermillion will successfully license or otherwise successfully partner with third parties to commercialize its future products; (6) uncertainty whether the trading in Vermillion's stock will become significantly less liquid; and (7) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this press release is as of the date of this report, and Vermillion expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Vermillion's expectations or any change in events, conditions or circumstances on which any such statement is based, unless required by law.

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov.

(1) National Institutes of Health Publication No. 06-5837


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion Reports Results for the Second Quarter 2011
2. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
3. Vermillion Announces Joining Russell Microcap® Index
4. Vermillion Announces Notice of Allowance for Alzheimer Patent
5. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
6. Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011
7. Stephens Initiates Coverage on Vermillion
8. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
9. Vermillion Announces Issuance of European Patent
10. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
11. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... GMO corn cases filed across the United States, and ... being consolidated in a Kansas federal court for pretrial proceedings. ... Corn Litigation, MDL No. 2591 in the U.S. District Court ... GMO corn multidistrict litigation (MDL) has been handed over to ...
(Date:12/24/2014)... December 23, 2014 The report ... its definition, classification, application and industry overview. This ... product cost structure. Production is separated by regions, ... raw materials, equipment, downstream client survey, marketing channels, ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... LEUVEN, Belgium, September 11 , ... Nominations , ThromboGenics NV (Euronext Brussels: ... innovative treatments for eye,disease, vascular disease and cancer, announced today ... the Year" and "Licensing Deal of,the Year" awards at the ...
... ... Founder, David A. Dodd. , ... Beaufort, SC (Vocus) - The formation of RiversEdge BioVentures LLC is announced today by Principal ... a highly distinguished career, serving in executive positions in several major pharmaceutical and life sciences ...
... , , , ... today it has signed a provider agreement with Beech Street ... for healthcare management services. Beech Street will assist SpectraCell with ... an expanding laboratory. , , ...
Cached Biology Technology:ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009 2ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009 3RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 2SpectraCell Contracts With Beech Street Corporation 2
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... the addition of the "The Global Watermarking ... http://photos.prnewswire.com/prnh/20130307/600769 ... global digital media watermarking and fingerprinting markets. Watermarking ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ( ... Market Monitor: North America Perimeter Security Systems Market" report ... The North American perimeter security market is estimated ... 2019. Although the U.S. market holds a larger share in ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally ... for the first time a fingerprint sensor in its ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... wisdom teeth are not much more than an annoyance that ... in the September 17 Journal of Biological Chemistry ... for the creation of stem cells; thus, everyone might be ... he or she ever need some. Groundbreaking research back ...
... Mount Sinai School of Medicine have found that bisphenol A ... is detectable in the saliva after placement in children,s mouths. ... associated with changes in behavior, prostate and urinary tract development, ... the current issue of Pediatrics . Reins containing ...
... of Scots Pine trees, scientists have shown that the iconic ... the ancestors that colonised Britain after the end of the ... future populations, according to new results published in the journal ... an international team from the Centre for Ecology & Hydrology, ...
Cached Biology News:A smart use for wisdom teeth: Making stem cells 2Mount Sinai researchers analyze impact of chemical BPA in dental sealants used in children 2Scots Pine shows its continental roots 2
... Formula variant: With the ... by Murashige and Skoog (1962) ... by Gamborg, et al. (1968). ... contain 4.4 grams of powder ...
... The ProteinChip beta-amyloid Multipeptide Kit, designed ... makes detecting a variety of amyloid ... ever before. - Clinical neuroscience proteomics ... drug treatment - Correlate beta-amyloid peptide ...
... Total Canine Endostatin. Canine Cytokine ... products include a line of enzyme-linked ... reagents used for multiple research applications. ... are ultra-sensitive, quick and dependable assays. ...
... Surveyor software provides local instrument control ... HPLC Systems. The software operates on ... Windows Pocket PC 2002 O/S and ... directly to their Surveyor quaternary gradient ...
Biology Products: